🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsPublic SquareThe GLP Lounge Community Rules — Updated January 2026 Page 8

The GLP Lounge Community Rules — Updated January 2026

Admin Mon, Feb 12, 2024 at 6:40 PM 534 replies 45,480 viewsPage 8 of 20
Dr.EndoEP
Member
267
1,234
Oct 2024
El Paso, TX
Mar 3, 2024 at 9:10 AM#36
stefan_berlin said:
For anyone reading later: the numbers in this thread are worth checking against a primary source before you act on them, including mine.

Thank you for spelling out the reasoning rather than just the conclusion.

Last edited: Mar 3, 2024 at 11:10 AM
15 13NicoleRaleigh, james_edin, FranDenver and 12 others
Reply Quote Save Share Report
carl_compliance
Member
234
1,123
Nov 2024
Raleigh, NC
Mar 4, 2024 at 7:23 AM#37

Adding the clinical framing, because it changes how the question reads. Worth answering the question that was asked rather than the one behind it. The narrow version usually has an answer; the broad version usually does not, and answering the broad one is how a thread stops being useful.

16 14BrianDallas92, labquiet_amy, emily_PDX and 13 others
Reply Quote Save Share Report
bri_stats
Member
789
3,456
May 2024
Seattle, WA
Mar 5, 2024 at 5:36 AM#38
carl_compliance said:
Worth answering the question that was asked rather than the one behind it.

Adding a me-too, because a thread of one person's experience is not much use. Posting only so the count is not one.

17 15TomFromTexas, mike.trainer_LA, sarah_nash92 and 14 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
MounjBrad
Member
278
890
Oct 2024
Kentucky
Mar 6, 2024 at 3:48 AM#39
carl_compliance said:
Worth answering the question that was asked rather than the one behind it.

There is a second half to this that has not been said yet. The distinction that resolves most of these threads is between what is true on average and what is true for one person. Both are real; they answer different questions and get quoted as if they were the same one.

18 16pam_columbus, nick_SD_fit, ben_calgary and 15 others
Reply Quote Save Share Report
josh_phd_bmore
Member
389
1,678
Jul 2024
Baltimore, MD
Mar 7, 2024 at 2:00 AM#40

Adding the numbers, since they settle part of this. Say what you would expect to see if you were wrong, before you look. It is a small discipline and it changes what you notice.

Ask again with the specifics and you will get a better answer than this one.

40 13tampaLisa73, KarenAZ_mom, zoe_NC and 37 others
Reply Quote Save Share Report
167891020

Similar Threads

SELECT trial 4-year follow-up data released — sustained MACE reduction16 replies
GLP-1 receptor agonists and thyroid C-cell concerns — evidence review19 replies
Is there a ceiling effect for GLP-1-mediated weight loss?20 replies
Comparative pharmacokinetics: semaglutide vs tirzepatide vs retatrutide6 replies
My 18-month semaglutide journey — comprehensive data log20 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register